Table 2.

Number of patients presenting postsurgery complications and distribution of complications

Placebo n (%) N = 122Promestriene n (%) N = 119
Missing data6 (4.9)5 (4.2)
Patients presenting at 1 complication19 (16.4)17 (14.9)
Patients presenting no complication95 (77.9)96 (80.7)
Patients presenting 1 complication19 (15.6)17 (14.3)
Patients presenting 2 complications6 (4.9)4 (3.4)
Patients presenting 3 complications1 (0.8)2 (1.7)
Patients presenting 4 complications1 (0.8 )0 (0.0)
Number of patients presenting at least 1 complication (onlay surgery only)a15 (13.9)15 (14.0)
Placebo n (%) N = 122Promestriene n (%) N = 119
Missing data6 (4.9)5 (4.2)
Patients presenting at 1 complication19 (16.4)17 (14.9)
Patients presenting no complication95 (77.9)96 (80.7)
Patients presenting 1 complication19 (15.6)17 (14.3)
Patients presenting 2 complications6 (4.9)4 (3.4)
Patients presenting 3 complications1 (0.8)2 (1.7)
Patients presenting 4 complications1 (0.8 )0 (0.0)
Number of patients presenting at least 1 complication (onlay surgery only)a15 (13.9)15 (14.0)

aPlacebo: n = 114; promestriene: n = 111.

Table 2.

Number of patients presenting postsurgery complications and distribution of complications

Placebo n (%) N = 122Promestriene n (%) N = 119
Missing data6 (4.9)5 (4.2)
Patients presenting at 1 complication19 (16.4)17 (14.9)
Patients presenting no complication95 (77.9)96 (80.7)
Patients presenting 1 complication19 (15.6)17 (14.3)
Patients presenting 2 complications6 (4.9)4 (3.4)
Patients presenting 3 complications1 (0.8)2 (1.7)
Patients presenting 4 complications1 (0.8 )0 (0.0)
Number of patients presenting at least 1 complication (onlay surgery only)a15 (13.9)15 (14.0)
Placebo n (%) N = 122Promestriene n (%) N = 119
Missing data6 (4.9)5 (4.2)
Patients presenting at 1 complication19 (16.4)17 (14.9)
Patients presenting no complication95 (77.9)96 (80.7)
Patients presenting 1 complication19 (15.6)17 (14.3)
Patients presenting 2 complications6 (4.9)4 (3.4)
Patients presenting 3 complications1 (0.8)2 (1.7)
Patients presenting 4 complications1 (0.8 )0 (0.0)
Number of patients presenting at least 1 complication (onlay surgery only)a15 (13.9)15 (14.0)

aPlacebo: n = 114; promestriene: n = 111.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close